Dr. Lal PathLabs Limited (NSE: LALPATHLAB) reported a Revenue from Operations of ₹489.4 Crores, a decline of 1.5% from the previous year. The Consolidated Net Profit for the business also decreased by 8% year over year, to ₹53.6 Crore from ₹58.2 Crore. Earnings per Share is ₹6.35 for this quarter.
Dr. Lal PathLabs Limited Q3 FY23; Net Profit Down By 8%
Tags: Healthcare Services
Related Post
- NLC India Ltd Q2FY25; 10% fall in Profits
NLC India is engaged in the business of mining of lignite and generation of power…
-
NHPC Ltd Q2FY25; 37% fall in Profits
NHPC, a Mini Ratna category I public sector utility, is Government of India’s flagship hydroelectric…
-
Ashok Leyland Ltd Q2FY25; 35% rise in Profits
Ashok Leyland is the flagship Company of the Hinduja group, having a long-standing presence in…